A class of drugs designed as a targeted therapy for the treatment of people with cancer. They are composed of two parts: an antibody (e.g. Herceptin) linked to a chemotherapy medicine. The aim is that only cancer cells are targeted and that there is less impact on healthy non-cancer cells.
You are about to leave the site to one that is not affiliated to Roche Products (New Zealand) Ltd. Roche Products (New Zealand) does not endorse or control, the content of any linked websites and if you click OK, you agree that Roche has no responsibility or duty to you for anything that happens to you as a result. If the linked site is outside New Zealand’s jurisdiction, the information may not be consistent with New Zealand’s legislation, advertising codes or the relevant New Zealand registered Data Sheet. Please refer to the Data Sheet or Consumer Medicine Information on the Medsafe website for product information applicable to New Zealand.
Click OK to continue.
Ok Continue Close